Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron P Mitchell

Showing results (91-100 of 206) with videos related to

Pageof 21
Sort By:
Eclinicalmedicine|July 31, 2023
The cancer premium - explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional studyMiquel Serra-Burriel, Gellért Perényi, Yannic Laube, et al.
JAMA Network Open|January 13, 2026
Postmarket Safety Actions for Novel Oncology Drugs Granted FDA's Accelerated ApprovalMaryam Mooghali, Joshua D Wallach, Aaron P Mitchell, et al.
Biochemical and Biophysical Research Communications|October 26, 2007
A nucleosome positioned by alpha2/Mcm1 prevents Hap1 activator binding in vivoNobuyuki Morohashi, Kumiko Nakajima, Daichi Kurihara, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2020
Trends in Female Representation on NCCN Guideline PanelsPranammya Dey, Angela K Green, Michael Haddadin, et al.
The Oncologist|January 9, 2026
How Often Do Oncologists Receive Industry Payments from Competing Companies?Helen M Keetley, Ziad Zakaria, Grace Gallagher, et al.
Msphere|June 23, 2021
Intravital Imaging of Candida albicans Identifies Differential <i>In Vitro</i> and <i>In Vivo</i> Filamentation Phenotypes for Transcription Factor Deletion MutantsRohan S Wakade, Manning Huang, Aaron P Mitchell, et al.
Cancers|December 10, 2021
The Cost of Enfortumab Vedotin Wastage Due to Vial Size-A Real-World AnalysisMichal Sarfaty, Assaf Moore, Ashley M Regazzi, et al.
Eukaryotic Cell|August 7, 2012
cis- and trans-acting localization determinants of pH response regulator Rim13 in Saccharomyces cerevisiaeShoba Subramanian, Carol A Woolford, Jigar V Desai, et al.
The Oncologist|August 10, 2022
Physician Payments from Pharmaceutical Companies Related to Cancer DrugsAaron P Mitchell, Akriti Mishra Meza, Niti U Trivedi, et al.
Plos Pathogens|May 23, 2019
Circuit diversification in a biofilm regulatory networkManning Y Huang, Carol A Woolford, Gemma May, et al.
Pageof 21

Showing results (91-100 of 206) with videos related to

Sort By:
Pageof 21
Eclinicalmedicine|July 31, 2023
The cancer premium - explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional studyMiquel Serra-Burriel, Gellért Perényi, Yannic Laube, et al.
JAMA Network Open|January 13, 2026
Postmarket Safety Actions for Novel Oncology Drugs Granted FDA's Accelerated ApprovalMaryam Mooghali, Joshua D Wallach, Aaron P Mitchell, et al.
Biochemical and Biophysical Research Communications|October 26, 2007
A nucleosome positioned by alpha2/Mcm1 prevents Hap1 activator binding in vivoNobuyuki Morohashi, Kumiko Nakajima, Daichi Kurihara, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2020
Trends in Female Representation on NCCN Guideline PanelsPranammya Dey, Angela K Green, Michael Haddadin, et al.
The Oncologist|January 9, 2026
How Often Do Oncologists Receive Industry Payments from Competing Companies?Helen M Keetley, Ziad Zakaria, Grace Gallagher, et al.
Msphere|June 23, 2021
Intravital Imaging of Candida albicans Identifies Differential <i>In Vitro</i> and <i>In Vivo</i> Filamentation Phenotypes for Transcription Factor Deletion MutantsRohan S Wakade, Manning Huang, Aaron P Mitchell, et al.
Cancers|December 10, 2021
The Cost of Enfortumab Vedotin Wastage Due to Vial Size-A Real-World AnalysisMichal Sarfaty, Assaf Moore, Ashley M Regazzi, et al.
Eukaryotic Cell|August 7, 2012
cis- and trans-acting localization determinants of pH response regulator Rim13 in Saccharomyces cerevisiaeShoba Subramanian, Carol A Woolford, Jigar V Desai, et al.
The Oncologist|August 10, 2022
Physician Payments from Pharmaceutical Companies Related to Cancer DrugsAaron P Mitchell, Akriti Mishra Meza, Niti U Trivedi, et al.
Plos Pathogens|May 23, 2019
Circuit diversification in a biofilm regulatory networkManning Y Huang, Carol A Woolford, Gemma May, et al.
Pageof 21